Saylor signals Strategy is ‘Back’ to Bitcoin buying

abstrak:Saylor‘s “We’re Back” post hints Strategy is preparing to resume Bitcoin purchases after a two-month pause focused on bolstering its balance sheet.

Strategy‘s Michael Saylor said “We’re Back” in his latest signal on X (formerly Twitter) of the companys likely return to Bitcoin buying.

For market watchers, the post could be a strong psychological signal as Saylor has a track record of dropping cryptic weekend teasers that precede official Monday morning treasury purchase announcements.

Should that record, and community interpretation, hold true, his post points to the resumption of corporate Bitcoin accumulation following a notable summer hiatus.

To put the message in context, over the past two months, Strategy paused its regular weekly Bitcoin buying spree. Instead of expanding its crypto holdings, management pivoted toward bolstering its balance sheet. The firm focused on stabilizing its preferred stock offerings, building a $5.1 billion US dollar reserve, and introducing a dedicated $1.59 billion cash pool generated through massive common stock offerings.

Related: Strategys $66B Bitcoin machine hinges on capital markets, not BTC price: Report

This strategic breather coincided with a challenging market stretch that left Strategys industry-biggest BTC treasury sitting deep in the red on paper. However, recent macro momentum has propelled Bitcoin past the $80,000 threshold.

Because Strategy holds more than 840,447 Bitcoin at an average cost basis hovering around $75,385, the recent price recovery has pushed the firms overall position back into positive territory for the first time in months.

Saylor‘s “We’re Back” declaration functions on multiple levels. Operationally, it likely signals that the company is ready to deploy its considerable dry powder back into the asset class it champions. Psychologically, it marks a triumphant return to profitability and a renewed offensive for the worlds largest corporate Bitcoin treasury.

Disclaimer

Ang mga pananaw sa artikulong ito ay kumakatawan lamang sa mga personal na pananaw ng may-akda at hindi bumubuo ng payo sa pamumuhunan para sa platform na ito. Ang platform na ito ay hindi ginagarantiyahan ang kawastuhan, pagkakumpleto at pagiging maagap na impormasyon ng artikulo, o mananagot din para sa anumang pagkawala na sanhi ng paggamit o pag-asa ng impormasyon ng artikulo.
Nakaraang post

Top 10 S&P 500 Stocks nitong Dekada, May Isang Malinaw na Tema

Susunod

Sumisikat na Pampanoteng Biotech, Bagong Bet ng Wall Street para sa Growth